Koyfin Home > Directory > Health Care > Acadia Pharmaceutica

Acadia Pharmaceutica Price Chart ACAD

Historical daily share price chart and data for Acadia Pharmaceutica since 2004 adjusted for splits and dividends. The latest closing price for Acadia Pharmaceutica as of September 18, 2020 is $42.42.
  • In 2020 the stock opened at $42.87 and closed at $42.42 for a loss of -1% YTD.
  • In 2019 the stock opened at $15.84 and closed at $42.78 for a gain of 63%.
  • In 2018 the stock opened at $30.39 and closed at $16.17 for a loss of -88%.
  • In 2017 the stock opened at $29.13 and closed at $30.11 for a gain of 3%.
View Chart On Koyfin

Acadia Pharmaceutica Summary

Stock Symbol: ACAD

Acadia Pharmaceutica Company Info

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis. It is also developing pimavanserin as a treatment for dementia-related psychosis and as an adjunctive treatment for schizophrenia that are in Phase III clinical trials; and pimavanserin as an adjunctive treatment for major depressive disorder. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.
Market Cap
6.7b
Dividend Yield
0 %
Beta vs SPX
-0.29
Short Interest
934.14 %
30D Volatility
38.55
Hedge Fund Held
35.68 %
Competitors

Last 10 Days of ACAD Prices

09/18/2020$42.42
09/17/2020$40.76
09/16/2020$39.20
09/15/2020$38.79
09/14/2020$38.61
09/11/2020$36.62
09/10/2020$36.42
09/09/2020$37.90
09/08/2020$38.20
09/04/2020$38.27